Literature DB >> 30529759

A non-canonical JAGGED1 signal to JAK2 mediates osteoblast commitment in cranial neural crest cells.

Archana Kamalakar1, Melissa S Oh2, Yvonne C Stephenson3, Samir A Ballestas-Naissir4, Michael E Davis5, Nick J Willett6, Hicham M Drissi7, Steven L Goudy8.   

Abstract

During craniofacial development, cranial neural crest (CNC) cells migrate into the developing face and form bone through intramembranous ossification. Loss of JAGGED1 (JAG1) signaling in the CNC cells is associated with maxillary hypoplasia or maxillary bone deficiency (MBD) in mice and recapitulates the MBD seen in humans with Alagille syndrome. JAGGED1, a membrane-bound NOTCH ligand, is required for normal craniofacial development, and Jagged1 mutations in humans are known to cause Alagille Syndrome, which is associated with cardiac, biliary, and bone phenotypes and these children experience increased bony fractures. Previously, we demonstrated deficient maxillary osteogenesis in Wnt1-cre;Jagged1f/f (Jag1CKO) mice by conditional deletion of Jagged1 in maxillary CNC cells. In this study, we investigated the JAG1 signaling pathways in a CNC cell line. Treatment with JAG1 induced osteoblast differentiation and maturation markers, Runx2 and Ocn, respectively, Alkaline Phosphatase (ALP) production, as well as classic NOTCH1 targets, Hes1 and Hey1. While JAG1-induced Hes1 and Hey1 expression levels were predictably decreased after DAPT (NOTCH inhibitor) treatment, JAG1-induced Runx2 and Ocn levels were surprisingly constant in the presence of DAPT, indicating that JAG1 effects in the CNC cells are independent of the canonical NOTCH pathway. JAG1 treatment of CNC cells increased Janus Kinase 2 (JAK2) phosphorylation, which was refractory to DAPT treatment, highlighting the importance of the non-canonical NOTCH pathway during CNC cells osteoblast commitment. Pharmacologic inhibition of JAK2 phosphorylation, with and without DAPT treatment, upon JAG1 induction reduced ALP production and, Runx2 and Ocn gene expression. Collectively, these data suggest that JAK2 is an essential component downstream of a non-canonical JAG1-NOTCH1 pathway through which JAG1 stimulates expression of osteoblast-specific gene targets in CNC cells that contribute to osteoblast differentiation and bone mineralization.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  JAK2; Maxillary bone disease; Maxillary development; Non-canonical JAGGED1 signaling; Osteoblast commitment

Year:  2018        PMID: 30529759      PMCID: PMC6420215          DOI: 10.1016/j.cellsig.2018.12.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  43 in total

Review 1.  Ligand-dependent Notch signaling in vascular formation.

Authors:  Tsutomu Kume
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Controlled JAGGED1 delivery induces human embryonic palate mesenchymal cells to form osteoblasts.

Authors:  Jean De La Croix Ndong; Yvonne Stephenson; Michael E Davis; Andrés J García; Steven Goudy
Journal:  J Biomed Mater Res A       Date:  2017-11-15       Impact factor: 4.396

3.  Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1.

Authors:  Y Xue; X Gao; C E Lindsell; C R Norton; B Chang; C Hicks; M Gendron-Maguire; E B Rand; G Weinmaster; T Gridley
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

4.  BMP2 signals loss of epithelial character in epicardial cells but requires the Type III TGFβ receptor to promote invasion.

Authors:  Cynthia R Hill; Nora S Sanchez; Joseph D Love; Julian A Arrieta; Charles C Hong; Christopher B Brown; Anita F Austin; Joey V Barnett
Journal:  Cell Signal       Date:  2012-01-03       Impact factor: 4.315

5.  Manic fringe and lunatic fringe modify different sites of the Notch2 extracellular region, resulting in different signaling modulation.

Authors:  K Shimizu; S Chiba; T Saito; K Kumano; T Takahashi; H Hirai
Journal:  J Biol Chem       Date:  2001-05-09       Impact factor: 5.157

6.  Variable expression of Alagille syndrome in a family with a new JAG1 gene mutation.

Authors:  Victoria C Ziesenitz; Tsvetomir Loukanov; Christiane Gläser; Matthias Gorenflo
Journal:  Cardiol Young       Date:  2015-01-23       Impact factor: 1.093

7.  Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression.

Authors:  Vindhya Palagani; Przemyslaw Bozko; Mona El Khatib; Hanane Belahmer; Nathalia Giese; Bence Sipos; Nisar P Malek; Ruben R Plentz
Journal:  Carcinogenesis       Date:  2013-11-30       Impact factor: 4.944

8.  A dosage-dependent role for Spry2 in growth and patterning during palate development.

Authors:  Ian C Welsh; Aaron Hagge-Greenberg; Timothy P O'Brien
Journal:  Mech Dev       Date:  2007-07-10       Impact factor: 1.882

9.  Polycystins and mechanotransduction in bone.

Authors:  Antonios N Gargalionis; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  Oncotarget       Date:  2017-11-13

10.  High-Resolution Epigenomic Atlas of Human Embryonic Craniofacial Development.

Authors:  Andrea Wilderman; Jennifer VanOudenhove; Jeffrey Kron; James P Noonan; Justin Cotney
Journal:  Cell Rep       Date:  2018-05-01       Impact factor: 9.423

View more
  4 in total

Review 1.  Gene regulatory network from cranial neural crest cells to osteoblast differentiation and calvarial bone development.

Authors:  Junguang Liao; Yuping Huang; Qiang Wang; Sisi Chen; Chenyang Zhang; Dan Wang; Zhengbing Lv; Xingen Zhang; Mengrui Wu; Guiqian Chen
Journal:  Cell Mol Life Sci       Date:  2022-02-27       Impact factor: 9.261

2.  JAGGED1 stimulates cranial neural crest cell osteoblast commitment pathways and bone regeneration independent of canonical NOTCH signaling.

Authors:  Archana Kamalakar; Jay M McKinney; Daniel Salinas Duron; Angelica M Amanso; Samir A Ballestas; Hicham Drissi; Nick J Willett; Pallavi Bhattaram; Andrés J García; Levi B Wood; Steven L Goudy
Journal:  Bone       Date:  2020-09-25       Impact factor: 4.626

3.  Functional Diversification of SRSF Protein Kinase to Control Ubiquitin-Dependent Neurodevelopmental Signaling.

Authors:  Francisco Bustos; Anna Segarra-Fas; Gino Nardocci; Andrew Cassidy; Odetta Antico; Lindsay Davidson; Lennart Brandenburg; Thomas J Macartney; Rachel Toth; C James Hastie; Jennifer Moran; Robert Gourlay; Joby Varghese; Renata F Soares; Martin Montecino; Greg M Findlay
Journal:  Dev Cell       Date:  2020-10-19       Impact factor: 12.270

4.  The miR-98-3p/JAG1/Notch1 axis mediates the multigenerational inheritance of osteopenia caused by maternal dexamethasone exposure in female rat offspring.

Authors:  Hui Han; Hao Xiao; Zhixin Wu; Liang Liu; Ming Chen; Hanwen Gu; Hui Wang; Liaobin Chen
Journal:  Exp Mol Med       Date:  2022-03-24       Impact factor: 12.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.